# Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis

> **NCT00242164** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 25 (estimated)

## Conditions studied

- Chronic Kidney Disease
- Arrhythmia

## Interventions

- **DRUG:** Dialysate Magnesium (Concentration)

## Key facts

- **NCT ID:** NCT00242164
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-06
- **Final completion:** 2006-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2014-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00242164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00242164, "Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00242164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*